Antonio Torres

Summary

Country: Spain

Publications

  1. ncbi request reprint Levofloxacin for the treatment of respiratory tract infections
    Antoni Torres
    University of Barcelona, Respiratory Department, Villarroel 170 Barcelona 08036, Spain
    Expert Opin Pharmacother 13:1203-12. 2012
  2. ncbi request reprint Biomarkers and community-acquired pneumonia: tailoring management with biological data
    Antoni Torres
    Department of Pneumology, Clinic Institute of Thorax, Hospital Clinic of Barcelona Institut d Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Semin Respir Crit Care Med 33:266-71. 2012
  3. ncbi request reprint Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
    A Torres
    Servei de Pneumologia, Hospital Clinic de Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Ciber de enfermedades respiratorias CIBERES, University of Barcelona, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 34:19-31. 2015
  4. ncbi request reprint Corticosteroids as adjunctive treatment in community-acquired pneumonia
    O Sibila
    Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Minerva Anestesiol 80:1336-44. 2014
  5. pmc Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
    Stefano Aliberti
    Department of Pathophysiology and Transplantation, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, University of Milan, Via F, Sforza 35, Milan, Italy
    Respir Res 15:27. 2014
  6. pmc Inflammatory response in mixed viral-bacterial community-acquired pneumonia
    Salvador Bello
    Servicio de Neumologia, Hospital Universitario Miguel Servet, Paseo Isabel la católica, 1 3, 50009 Zaragoza, Spain
    BMC Pulm Med 14:123. 2014
  7. pmc Predicting treatment failure in patients with community acquired pneumonia: a case-control study
    Ignacio Martin-Loeches
    Hospital Clinic, IDIBAPS, Universitat de Barcelona, CIBER Enfermedades Respiratorias, Servei de Pneumologia, Institut del Tòrax, Villarroel 170, 08036 Barcelona, Spain
    Respir Res 15:75. 2014
  8. pmc The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review
    A Torres
    Servei de Pneumologia, Hospital Clinic de Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Ciber de enfermedades respiratorias CIBERES, University of Barcelona, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 33:1065-79. 2014
  9. pmc Risk factors for community-acquired pneumonia in adults in Europe: a literature review
    Antoni Torres
    Servei de Pneumologia, Hospital Clinic de Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Ciber de enfermedades respiratorias CIBERES, University of Barcelona, Barcelona, Spain
    Thorax 68:1057-65. 2013
  10. pmc Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study
    Arturo Huerta
    Department of Pneumology, Institute of Thorax ICT, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona UB, CIBER de Enfermedades Respiratorias CIBERES 06 06 0028, Villarroel 170, 08037 Barcelona, Spain
    Respir Res 15:17. 2014

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Levofloxacin for the treatment of respiratory tract infections
    Antoni Torres
    University of Barcelona, Respiratory Department, Villarroel 170 Barcelona 08036, Spain
    Expert Opin Pharmacother 13:1203-12. 2012
    ..High-dose (750 mg), short-course (5 days) therapy regimens may offer improved treatment, especially in HAP, due to higher drug concentrations, increased adherence and the potential to reduce the development of resistance...
  2. ncbi request reprint Biomarkers and community-acquired pneumonia: tailoring management with biological data
    Antoni Torres
    Department of Pneumology, Clinic Institute of Thorax, Hospital Clinic of Barcelona Institut d Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Semin Respir Crit Care Med 33:266-71. 2012
    ..Data from the literature appear to support the use of biomarkers in routine clinical practice to improve the decision making in CAP...
  3. ncbi request reprint Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
    A Torres
    Servei de Pneumologia, Hospital Clinic de Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Ciber de enfermedades respiratorias CIBERES, University of Barcelona, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 34:19-31. 2015
    ..Between 2011 and 2013, PCV13 received market authorisation by the European Medicines Agency (EMA) for these additional age groups and is now available in Europe for the prevention of pneumococcal disease in all age groups. ..
  4. ncbi request reprint Corticosteroids as adjunctive treatment in community-acquired pneumonia
    O Sibila
    Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Minerva Anestesiol 80:1336-44. 2014
    ..This review discusses the association of corticosteroids as adjunctive therapy and its association with clinical outcomes and side effects in patients with CAP. ..
  5. pmc Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
    Stefano Aliberti
    Department of Pathophysiology and Transplantation, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, University of Milan, Via F, Sforza 35, Milan, Italy
    Respir Res 15:27. 2014
    ..The aim of the study was to evaluate prevalence, characteristics, risk factors and impact on mortality of hospitalized patients with CAP according to the presence of ARF and SS on admission...
  6. pmc Inflammatory response in mixed viral-bacterial community-acquired pneumonia
    Salvador Bello
    Servicio de Neumologia, Hospital Universitario Miguel Servet, Paseo Isabel la católica, 1 3, 50009 Zaragoza, Spain
    BMC Pulm Med 14:123. 2014
    ..We wanted to investigate this profile of mixed viral-bacterial infection and to compare it to monomicrobial bacterial or viral CAP...
  7. pmc Predicting treatment failure in patients with community acquired pneumonia: a case-control study
    Ignacio Martin-Loeches
    Hospital Clinic, IDIBAPS, Universitat de Barcelona, CIBER Enfermedades Respiratorias, Servei de Pneumologia, Institut del Tòrax, Villarroel 170, 08036 Barcelona, Spain
    Respir Res 15:75. 2014
    ..Those patients have increased mortality and are a target population for randomized clinical trials...
  8. pmc The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review
    A Torres
    Servei de Pneumologia, Hospital Clinic de Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Ciber de enfermedades respiratorias CIBERES, University of Barcelona, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 33:1065-79. 2014
    ....
  9. pmc Risk factors for community-acquired pneumonia in adults in Europe: a literature review
    Antoni Torres
    Servei de Pneumologia, Hospital Clinic de Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Ciber de enfermedades respiratorias CIBERES, University of Barcelona, Barcelona, Spain
    Thorax 68:1057-65. 2013
    ..Community-acquired pneumonia (CAP) causes considerable morbidity and mortality in adults, particularly in the elderly...
  10. pmc Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study
    Arturo Huerta
    Department of Pneumology, Institute of Thorax ICT, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona UB, CIBER de Enfermedades Respiratorias CIBERES 06 06 0028, Villarroel 170, 08037 Barcelona, Spain
    Respir Res 15:17. 2014
    ..However, the importance of Aspergillus spp. in the clinical management of AECOPD still remains unclear...
  11. pmc Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients
    Ignacio Martin-Loeches
    Critical Care Center, Parc Taulí Hospital Sabadell, CibeRes, Sabadell, Spain
    Crit Care 15:R286. 2011
    ..There is a vast amount of information published regarding the impact of 2009 pandemic Influenza A (pH1N1) virus infection. However, a comparison of risk factors and outcome during the 2010-2011 post-pandemic period has not been described...
  12. pmc Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease
    Marc Miravitlles
    Fundació Clínic, Institut d Investigacions Biomediques August Pi i Sunyer, CIBER de Enfermedades Respiratorias, Barcelona, Spain
    Respir Res 11:58. 2010
    ..Bacterial colonisation in chronic obstructive pulmonary disease (COPD) contributes to airway inflammation and modulates exacerbations. We assessed risk factors for bacterial colonisation in COPD...
  13. pmc Does ventilator-associated tracheobronchitis need antibiotic treatment?
    Antonio Torres
    Department of Pulmonology and Critical Care, Hospital Clinic, IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
    Crit Care 9:255-6. 2005
    ..We will discuss the strengths and drawbacks of the article on this topic published in this issue by Nseir et al...
  14. ncbi request reprint Treatment failure in patients with ventilator-associated pneumonia
    Amalia Alcón Domínguez
    Anesthesia Department, Hospital Clinic, Barcelona, Spain
    Semin Respir Crit Care Med 27:104-14. 2006
    ..Treatment failure can be defined by the pattern of resolution of VAP, which is clearly established in the literature...
  15. ncbi request reprint Microbiologic features and outcome of pneumonia in transplanted patients
    Carlos Cervera
    Services of Infectious Diseases, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain
    Diagn Microbiol Infect Dis 55:47-54. 2006
    ..001). SOT patients with nosocomial pneumonia, or those who needed mechanical ventilation, had a high mortality rate and benefits from the fiberoptic diagnostic techniques...
  16. ncbi request reprint Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system
    Elisa García-Vázquez
    Department of Infectious Diseases, Hospital Clinic, Barcelona, Spain
    Arch Intern Med 164:1807-11. 2004
    ..The usefulness of sputum culture in guiding microbiological diagnosis of community-acquired pneumonia is controversial. We evaluate and assess it using the Patients Outcome Research Team (PORT) predictive scoring system...
  17. ncbi request reprint Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic
    R Riquelme
    Universidad San Sebastian, Servicia de Medicina Interna, Hospital de Puerto Montt, Puerto Montt, Spain
    Eur Respir J 38:106-11. 2011
    ....
  18. ncbi request reprint Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
    Lionel A Mandell
    McMaster University Medical School, Hamilton, Ontario, Canada
    Clin Infect Dis 44:S27-72. 2007
  19. doi request reprint Guideline tyranny: a response to the article by Baum and Kaltsas
    Lionel Mandell
    Clin Infect Dis 47:1117-8. 2008
  20. pmc The PIRO concept: I is for infection
    Jean Louis Vincent
    Department of Intensive Care, Erasme Hospital, Free University of Brussels, Brussels, Belgium
    Crit Care 7:252-5. 2003
  21. ncbi request reprint Accuracy of BRT and Delvotest microbial inhibition tests as affected by composition of ewe's milk
    Rafael Althaus
    Departamento de Ciencia Animal, Universidad Politecnica de Valencia, Camino de Vera, 14, Apartado 22012, 46071 Valencia, Spain
    J Food Prot 66:473-8. 2003
    ..18 mg/liter versus 6.85 mg/liter). Further analyses are needed to confirm the possible presence of antimicrobial residues in this particular type of milk sample...